Insulet (PODD) Non-cash Items (2011 - 2012)
Insulet posted quarterly Non-cash Items of $1.5 million for Q4 2012, down 93.21% year-on-year from $22.7 million in Q1 2012, and down 5.27% on a QoQ basis from $1.6 million in Q3 2012.
Insulet (PODD) has 2 years of Non-cash Items data on file, last reported at $1.5 million in Q4 2012.
- For the quarter ending Q4 2012, Non-cash Items fell 93.21% year-over-year to $1.5 million; the trailing twelve-month figure through Dec 2012 stood at $1.5 million (down 93.21% YoY), and the FY2012 full-year result was $1.5 million, down 93.21% from the prior year.
- Non-cash Items for Q4 2012 stood at $1.5 million, down from $1.6 million in the prior quarter.
- Across five years, Non-cash Items topped out at $25.3 million in Q2 2012 and bottomed at $1.5 million in Q4 2012.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Insulet | 10.37 Bn | 9.89 Bn | 529.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | 1.54 Mn |
| Dec 31, 2012 | 1.54 Mn |
| Sep 30, 2012 | 1.63 Mn |
| Sep 30, 2012 | 1.63 Mn |
| Jun 30, 2012 | 25.33 Mn |
| Jun 30, 2012 | 25.33 Mn |
| Mar 31, 2012 | 1.71 Mn |
| Mar 31, 2012 | 1.71 Mn |
| Dec 31, 2011 | 22.67 Mn |
| Dec 31, 2011 | 22.67 Mn |